{"id":29824,"date":"2020-07-19T08:13:34","date_gmt":"2020-07-19T08:13:34","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=29824"},"modified":"2023-09-03T08:21:14","modified_gmt":"2023-09-03T08:21:14","slug":"tranylcypromine","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/","title":{"rendered":"Tranylcypromine"},"content":{"rendered":"<p>A nonselective and irreversible monoamine oxidase inhibitor (MAOI) antidepressant medication used principally to treat depression in patients who have failed to respond to more standard treatments. Marketed under the brand name parnate.<\/p>\n<hr \/>\n<p>An MAO inhibitor used as an antidepressant. Parnate is a commercial preparation.<\/p>\n<hr \/>\n<p>An antidepressant drug, one of the MAO inhibitors, given by mouth for the treatment of severe mental depressive states. Common side-effects include restlessness, insomnia, giddiness, and a fall in blood pressure.<\/p>\n<hr \/>\n<p>One of the monoamine oxidase inhibitor antidepressant drugs.<\/p>\n<hr \/>\n<p>This antidepressant medication falls within the monoamine oxidase inhibitor (MAOI) category and is primarily prescribed for individuals grappling with severe depression.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A nonselective and irreversible monoamine oxidase inhibitor (MAOI) antidepressant medication used principally to treat depression in patients who have failed to respond to more standard treatments. Marketed under the brand name parnate. An MAO inhibitor used as an antidepressant. Parnate is a commercial preparation. An antidepressant drug, one of the MAO inhibitors, given by mouth [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-29824","post","type-post","status-publish","format-standard","hentry","category-t"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Tranylcypromine - Definition of Tranylcypromine<\/title>\n<meta name=\"description\" content=\"A nonselective and irreversible monoamine oxidase inhibitor (MAOI) antidepressant medication used principally to treat depression in patients who have failed to respond to more standard treatments. Marketed under the brand name parnate.An MAO inhibitor used as an antidepressant. Parnate is a commercial preparation.An antidepressant drug, one of the MAO inhibitors, given by mouth for the treatment of severe mental depressive states. Common side-effects include restlessness, insomnia, giddiness, and a fall in blood pressure.One of the monoamine oxidase inhibitor antidepressant drugs.This antidepressant medication falls within the monoamine oxidase inhibitor (MAOI) category and is primarily prescribed for individuals grappling with severe depression.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tranylcypromine - Definition of Tranylcypromine\" \/>\n<meta property=\"og:description\" content=\"A nonselective and irreversible monoamine oxidase inhibitor (MAOI) antidepressant medication used principally to treat depression in patients who have failed to respond to more standard treatments. Marketed under the brand name parnate.An MAO inhibitor used as an antidepressant. Parnate is a commercial preparation.An antidepressant drug, one of the MAO inhibitors, given by mouth for the treatment of severe mental depressive states. Common side-effects include restlessness, insomnia, giddiness, and a fall in blood pressure.One of the monoamine oxidase inhibitor antidepressant drugs.This antidepressant medication falls within the monoamine oxidase inhibitor (MAOI) category and is primarily prescribed for individuals grappling with severe depression.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-19T08:13:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-03T08:21:14+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/\",\"name\":\"Tranylcypromine - Definition of Tranylcypromine\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-19T08:13:34+00:00\",\"dateModified\":\"2023-09-03T08:21:14+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A nonselective and irreversible monoamine oxidase inhibitor (MAOI) antidepressant medication used principally to treat depression in patients who have failed to respond to more standard treatments. Marketed under the brand name parnate.An MAO inhibitor used as an antidepressant. Parnate is a commercial preparation.An antidepressant drug, one of the MAO inhibitors, given by mouth for the treatment of severe mental depressive states. Common side-effects include restlessness, insomnia, giddiness, and a fall in blood pressure.One of the monoamine oxidase inhibitor antidepressant drugs.This antidepressant medication falls within the monoamine oxidase inhibitor (MAOI) category and is primarily prescribed for individuals grappling with severe depression.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tranylcypromine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tranylcypromine - Definition of Tranylcypromine","description":"A nonselective and irreversible monoamine oxidase inhibitor (MAOI) antidepressant medication used principally to treat depression in patients who have failed to respond to more standard treatments. Marketed under the brand name parnate.An MAO inhibitor used as an antidepressant. Parnate is a commercial preparation.An antidepressant drug, one of the MAO inhibitors, given by mouth for the treatment of severe mental depressive states. Common side-effects include restlessness, insomnia, giddiness, and a fall in blood pressure.One of the monoamine oxidase inhibitor antidepressant drugs.This antidepressant medication falls within the monoamine oxidase inhibitor (MAOI) category and is primarily prescribed for individuals grappling with severe depression.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/","og_locale":"en_US","og_type":"article","og_title":"Tranylcypromine - Definition of Tranylcypromine","og_description":"A nonselective and irreversible monoamine oxidase inhibitor (MAOI) antidepressant medication used principally to treat depression in patients who have failed to respond to more standard treatments. Marketed under the brand name parnate.An MAO inhibitor used as an antidepressant. Parnate is a commercial preparation.An antidepressant drug, one of the MAO inhibitors, given by mouth for the treatment of severe mental depressive states. Common side-effects include restlessness, insomnia, giddiness, and a fall in blood pressure.One of the monoamine oxidase inhibitor antidepressant drugs.This antidepressant medication falls within the monoamine oxidase inhibitor (MAOI) category and is primarily prescribed for individuals grappling with severe depression.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/","og_site_name":"Glossary","article_published_time":"2020-07-19T08:13:34+00:00","article_modified_time":"2023-09-03T08:21:14+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/","name":"Tranylcypromine - Definition of Tranylcypromine","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-19T08:13:34+00:00","dateModified":"2023-09-03T08:21:14+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A nonselective and irreversible monoamine oxidase inhibitor (MAOI) antidepressant medication used principally to treat depression in patients who have failed to respond to more standard treatments. Marketed under the brand name parnate.An MAO inhibitor used as an antidepressant. Parnate is a commercial preparation.An antidepressant drug, one of the MAO inhibitors, given by mouth for the treatment of severe mental depressive states. Common side-effects include restlessness, insomnia, giddiness, and a fall in blood pressure.One of the monoamine oxidase inhibitor antidepressant drugs.This antidepressant medication falls within the monoamine oxidase inhibitor (MAOI) category and is primarily prescribed for individuals grappling with severe depression.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/tranylcypromine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Tranylcypromine"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=29824"}],"version-history":[{"count":6,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29824\/revisions"}],"predecessor-version":[{"id":239388,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29824\/revisions\/239388"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=29824"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=29824"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=29824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}